Detailed information for compound 1960832

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 296.367 | Formula: C17H20N4O
  • H donors: 1 H acceptors: 2 LogP: 1.71 Rotable bonds: 1
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C1N(CCc2c3c1cccc3[nH]n2)[C@@H]1CN2CCC1CC2
  • InChi: 1S/C17H20N4O/c22-17-12-2-1-3-13-16(12)14(19-18-13)6-9-21(17)15-10-20-7-4-11(15)5-8-20/h1-3,11,15H,4-10H2,(H,18,19)/t15-/m1/s1
  • InChiKey: WHLXDRXTKZLGFK-OAHLLOKOSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi Cation transporter family protein 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic 484 aa 469 aa 28.6 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma brucei thymidylate kinase, putative 0.0125 1 0.5
Trichomonas vaginalis thymidylate kinase, putative 0.0125 1 0.5
Leishmania major thymidylate kinase-like protein 0.0125 1 1
Chlamydia trachomatis thymidylate kinase 0.0125 1 0.5
Echinococcus multilocularis thymidylate kinase 0.0125 1 1
Schistosoma mansoni hypothetical protein 0.0125 1 1
Giardia lamblia CDC8 0.0125 1 0.5
Schistosoma mansoni thymidylate kinase 0.0125 1 1
Echinococcus granulosus thymidylate kinase 0.0125 1 1
Schistosoma mansoni thymidylate kinase 0.0125 1 1
Plasmodium vivax thymidylate kinase, putative 0.0125 1 0.5
Mycobacterium ulcerans thymidylate kinase 0.0125 1 0.5
Wolbachia endosymbiont of Brugia malayi thymidylate kinase 0.0125 1 0.5
Mycobacterium leprae probable thymidylate kinase Tmk (dTMP KINASE) (THYMIDYLIC ACID KINASE) (TMPK) 0.0125 1 0.5
Trichomonas vaginalis thymidylate kinase, putative 0.0125 1 0.5
Trypanosoma cruzi thymidylate kinase, putative 0.0125 1 1
Mycobacterium tuberculosis Thymidylate kinase Tmk (dTMP kinase) (thymidylic acid kinase) (TMPK) 0.0125 1 0.5
Entamoeba histolytica Thymidylate kinase, putative 0.0125 1 0.5
Plasmodium falciparum thymidylate kinase 0.0125 1 0.5
Toxoplasma gondii thymidylate kinase 0.0125 1 0.5
Treponema pallidum thymidylate kinase (tmk) 0.0125 1 0.5
Trypanosoma brucei thymidylate kinase, putative 0.0125 1 0.5
Onchocerca volvulus Putative thymidylate kinase 0.0125 1 1
Trypanosoma cruzi thymidylate kinase, putative 0.0125 1 1
Loa Loa (eye worm) thymidylate kinase 0.0125 1 1

Activities

Activity type Activity value Assay description Source Reference
Ki (binding) = 3 nM BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. ChEMBL. No reference
Ki (binding) = 4 nM BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.